Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2021 · 10-Q
Revenue$7.50M$7.50M−7.5% vs Q3 2020 Net Income$856.49K$856.49K+9.2% vs Q3 2020 EPS Diluted$0.10$0.10±0.0% vs Q3 2020 Operating Income$1,596,338−35.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$527,737−74.3% Margins · derivedOperating margin21.3%−9.3 pt vs Q3 2020
Net margin11.4%+1.7 pt vs Q3 2020
ended Aug 31, 2021 · filed Oct 15, 2021 · 45 d after period end